FieldLine launches HEDscan™, a next-generation device for non-invasive functional brain imaging

HEDscan is the world’s first, commercially-available, non-cryogenic, whole-head MEG system designed to expand the research and diagnosis of a broad range of mental health diseases

FieldLine Inc., a biotech company targeting advanced brain diagnostic technology, announced today the general availability of the FieldLine HEDscan system – the world’s first commercially available non-cryogenic, whole-head magnetoencephalography (MEG) system for functional brain imaging.

HEDscan is available to researchers interested in generating 3-dimensional videos of a subject’s brain activity. HEDscan incorporates 128 fully-synchronized quantum magnetic sensors, constructed using the Company’s proprietary microfabrication techniques. The data collected using HEDscan allows neuroscientists and clinicians to research and diagnose a variety of mental health disorders ranging from Alzheimers to PTSD.

“For the first time, non-cryogenic MEG will be accessible to the neuroscience market as an important tool for studying and treating the brain”, said Jeramy Hughes, co-founder of FieldLine. “HEDscan enables functional brain imaging in a broad subject population and at a price point that is accessible to most institutions. These devices will enable more extensive research into how the brain is affected in multiple mental health disorders.”

Recent studies have shown that this next generation technology can offer a clear improvement in signal-to-noise compared to previous MEG technologies. HEDscan further advances MEG with its non-cryogenic sensors and compact size. In addition, it is differentiated from previous MEG devices since subjects will be able to move freely during measurement by wearing only a light-weight cap that can fit a variety of head sizes. HEDscan can be placed in any room of any medical facility without the need for expensive building modifications. The Company will also sell the portable magnetic shielding along with the device, caps, and user software.

About MEG:
Magnetoencephalography is a non-invasive brain imaging technique that works by directly detecting tiny changes in magnetic fields produced by neuronal currents. It’s hallmark is high speed combined with high spatial resolution. Other brain imaging technologies either rely on slow and indirect measurements of the hemodynamic response (like fMRI and fNIRS), or give poor spatial information (like EEG).

About FieldLine:
FieldLine was founded in 2017 with the goal of creating a new MEG device that is affordable, easy to use, and provides greater functionality for researchers and clinicians wanting to understand how brain function varies in healthy versus diseased brains. FieldLine is currently accepting orders for HEDscan from the neuroscience research market. For information about purchasing HEDscan, please contact us at [email protected] or visit our website at

Media Contact:
Jeramy Hughes, [email protected], (720) 643-5813

More information on Innosphere’s MedTech client company who is shaping the future of neuroscience and mental health

FieldLine, Inc.
Description: FieldLine has developed a new brain imaging system that can significantly impact how we diagnose and treat neurological and mental disorders. Based on our state-of-the-art quantum sensors, FieldLine’s HEDscan system is a wearable magnetoencephalography (MEG) device capable of detecting neural activity directly and in real-time for high-resolution functional imaging. It can fit subjects ranging from infants to adults and accommodate movement during recording without loss in signal fidelity. The HEDscan platform is designed to be scalable and can be tailored to different applications. It can be placed in any room of any medical facility without the need for expensive building modifications as required by existing MEG systems. Our novel HEDscan device can considerably expand the use of MEG in the research and clinical markets and can be used broadly in support of mental health.

  • On the
  • Co-Founder: Orang Alem is a co-founder of FieldLine Inc. He started his career as an experimental physicist specializing in quantum sensors and atomic magnetometry. For the past 7 years, he has worked to commercialize this technology for biomedical applications, first as stand alone sensors at a previous start-up, and now at FieldLine as a turn-key brain imaging device.
  • Industries: MedTech, Biomedical Imaging, Research
  • Headquarters: Boulder, Colorado